ArticleAsia Pacific allergy2025

Phase II multicenter clinical trial of hypoallergenic 1BS-18 Hokushin bread oral immunotherapy for wheat-dependent exercise-induced anaphylaxis.

Kunie Kohno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.